Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection
Zhongyan Lu,Eric D Laing,Jarina Pena DaMata,Katherine Pohida,Marana S Tso,Emily C Samuels,Nusrat J Epsi,Batsukh Dorjbal,Camille Lake,Stephanie A Richard,Ryan C Maves,David A Lindholm,Julia S Rozman,Caroline English,Nikhil Huprikar,Katrin Mende,Rhonda E Colombo,Christopher J Colombo,Christopher C Broder,Anuradha Ganesan,Charlotte A Lanteri,Brian K Agan,David Tribble,Mark P Simons,Clifton L Dalgard,Paul W Blair,Josh Chenoweth,Simon D Pollett,Andrew L Snow,Timothy H Burgess,Allison M W Malloy,EPICC COVID-19 Cohort Study Group,J Cowden,S Deleon,A Markelz,K Mende,T Merritt,S Merritt,R Walter,T Wellington,S Bazan,P Kay,L Brandon,N Dimascio-Johnson,E Ewers,K Gallagher,D Larson,M Odom,A Rutt,D Clark,S Chambers,C Conlon,K Everson,P Faestel,T Ferguson,L Gordon,S Grogan,S Lis,C Mount,D Musfeldt,W Robb-McGrath,R Sainato,C Schofield,C Skinner,M Stein,M Switzer,M Timlin,S Wood,G Atwood,S Banks,R Carpenter,C Eickhoff,K Kronmann,T Lalani,T Lee,A Smith,R Tant,T Warkentien,J Arnold,C Berjohn,S Cammarata,S Husain,N Kirkland,A Lane,J Parrish,G Utz,S Chi,E Filan,K Fong,T Horseman,M Jones,A Kanis,A Kayatani,W Londeree,C Madar,J Masel,M McMahon,K Miyasato,G Murphy,V Ngauy,E Schoenman,C Uyehara,R Villacorta Lyew,C Byrne,K Chung,C Coles,C Fox,M Grother,D Gunasekera,P Hickey,J Livezey,C Morales,T Oliver,E Parmelee,J Rusiecki,M Sanchez-Edwards,A Scher,A Fries,I Barahona,M Oyeneyin,M Banda,B Davis,T Hunter,O Ikpekpe-Magege,S Kemp,R Mody,R Resendez,P Sandoval,M Wiggins
DOI: https://doi.org/10.1093/infdis/jiab543
2021-12-15
Abstract:Background: Characterizing the longevity and quality of cellular immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enhances understanding of coronavirus disease 2019 (COVID-19) immunity that influences clinical outcomes. Prior studies suggest SARS-CoV-2-specific T cells are present in peripheral blood 10 months after infection. Analysis of the function, durability, and diversity of cellular response long after natural infection, over a range of ages and disease phenotypes, is needed to identify preventative and therapeutic interventions. Methods: We identified participants in our multisite longitudinal, prospective cohort study 12 months after SARS-CoV-2 infection representing a range of disease severity. We investigated function, phenotypes, and frequency of T cells specific for SARS-CoV-2 using intracellular cytokine staining and spectral flow cytometry, and compared magnitude of SARS-CoV-2-specific antibodies. Results: SARS-CoV-2-specific antibodies and T cells were detected 12 months postinfection. Severe acute illness was associated with higher frequencies of SARS-CoV-2-specific CD4 T cells and antibodies at 12 months. In contrast, polyfunctional and cytotoxic T cells responsive to SARS-CoV-2 were identified in participants over a wide spectrum of disease severity. Conclusions: SARS-CoV-2 infection induces polyfunctional memory T cells detectable at 12 months postinfection, with higher frequency noted in those who experienced severe disease.